Status:
ENROLLING_BY_INVITATION
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b
Lead Sponsor:
University of Miami
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Medication Adherence
Mental Health Issue
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.
Eligibility Criteria
Inclusion
- Age: 18 years or older
- HIV positive
- Evidence of uncontrolled virus (e.g., \> 20 copies/ml) within the past 12 months as verified by medical record
- Group 1: (Men who have sex with men (MSM) who have used stimulants within the past 4 months (approximately 10 participants))OR Group 2: transgender women (approximately 10 participants) OR Group 3: Emerging adults between the ages of 18 and 26 (inclusive; approximately 10 participants)
Exclusion
- Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview
- Active untreated, unstable, major mental illness (i.e., untreated psychosis or mania) that would interfere with study participation
- Opinion of the PI that the participant would be at risk for harm to self or others
- Currently receiving CBT for a psychiatric disorder, or received a course of CBT in the past year.
Key Trial Info
Start Date :
August 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05352061
Start Date
August 15 2022
End Date
May 1 2027
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136